Related Experiment Video
Updated: Jun 5, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Lipid-lowering agent preferences among patients with hypercholesterolemia: a focus group study
Hei Hang Edmund Yiu1, Kehui Deng2, Lydia Wy Fung1,3
1Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, People's Republic of China.
Understanding patient preferences for lipid-lowering agents is crucial for improving adherence. Key barriers include knowledge gaps and pill burden, while effectiveness and cost influence choices.
Area of Science:
- Cardiology
- Pharmacoeconomics
- Patient Adherence Research
Background:
- Non-adherence to lipid-lowering agents significantly impacts patient outcomes and treatment efficacy.
- Limited understanding exists regarding patient preferences for lipid-lowering medication characteristics.
- Hypercholesterolemia management requires addressing patient-specific factors influencing treatment adherence.
Purpose of the Study:
- To qualitatively identify barriers to lipid-lowering medication adherence.
- To determine factors influencing lipid-lowering agent selection in hypercholesterolemia patients.
- To inform the design of a comprehensive medication preference study.
Main Methods:
- Focus group interviews with Cantonese-speaking hypercholesterolemia patients in Hong Kong.
- Thematic analysis of interview transcripts to identify key themes.
- Discrete Choice Experiment (DCE) method used for medication preference tasks.
Main Results:
- Identified adherence barriers: lack of knowledge, high pill burden, poor communication, limited involvement in decisions, side effects, and forgetfulness.
- Key factors influencing medication choice: treatment regimen, effectiveness, side effects, physician opinion, drug interactions, and out-of-pocket costs.
- Medication preference tasks effectively captured patient trade-offs.
Conclusions:
- Patient perspectives on adherence barriers and medication choice factors are critical for effective treatment selection.
- Incorporating patient preferences can enhance medication adherence.
- A large-scale DCE study is planned to quantify attribute importance for lipid-lowering agents.
More Related Videos
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Antihypertensive Drugs: Direct Renin Inhibitors

